Novel molecular optoelectronic nano-devices hybridized on micro chips for new functionality
Dr. Hilmi Volkan Demir
Bilkent University
Department of Physics and
Department of Electrical and Electronics Engineering
Nanotechnology Research Center
06533 Bilkent Ankara
Turkey
http://www.bilkent.edu.tr/~volkan/
Turkish citizen, Hilmi Volkan Demir, aged 30, is an assistant professor of Physics and Electrical Engineering and Associate Director of the Nanotechnology Research Center at Bilkent University in Ankara. Following a string of scholarships and prizes, he was awarded the Edward L. Ginzton Fellowship to study electrical engineering at Stanford University where he went on to receive his PhD .
With an outstanding number of publications, Dr. Demir’s scientific achievements have been recognised by a list of institutions and he has most recently received the Turkish National Academy of Sciences Distinguished Young Scientist Award, and the Junior Chamber International Young Outstanding Person Award, both in 2006.
At Bilkent University Nanotechnology Research Center, Demir and his research group have developed innovative hybrid nanophotonic devices that incorporate different types of nanostructures for the applications of lighting, imaging, sensing, and communications in a wide spectral range of UV-visible-IR.
In this project, they aim to develop and demonstrate a novel class of molecular-scale hybrid optoelectronic nanodevices that use semiconducting, conducting, and insulating nanoparticles and molecules integrated on micro-scale chips using combinations of different hybridization techniques.
With its ambitious end-goals, this project focuses on demonstrating the world’s first truly molecular optoelectronic devices that are ultimately controlled and constructed at nano scale in different proposed architectures to push the associated device performance to fundamental limits. By accessing these devices at the molecular scale, these proposed molecular optoelectronic nanodevices are expected to outperform their bulk and micro counterparts with unprecedented results.